Advertisement
Screener

GW PHARMACEUTICALS PLC Form PREM14A: Preliminary merger proxy statement

GW PHARMACEUTICALS PLC Form PREM14A: Preliminary merger proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-03-05: Form PREM14A; Period of report 2021-03-04; Description PREM14A; Document d320586dprem14a.htm.
FiledFormPeriod of reportDescriptionDocument
2021-03-05PREM14A2021-03-04PREM14Ad320586dprem14a.htm